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Abstract
Background—Despite the high heritability of alcohol dependence (AD), the genes found to be
associated with it account for only a small proportion of its total variability. The goal of this study
was to identify and analyze phenotypes based on homogeneous classes of individuals to increase
the power to detect genetic risk factors contributing to the risk of AD.
Methods—The 7 individual DSM-IV criteria for AD were analyzed using latent class analysis
(LCA) to identify classes defined by the pattern of endorsement of the criteria. A genome-wide
association study was performed in 118 extended European American families (n = 2,322
individuals) densely affected with AD to identify genes associated with AD, with each of the
seven DSM-IV criteria, and with the probability of belonging to two of three latent classes.
Results—Heritability for DSM-IV AD was 61%, and ranged from 17-60% for the other
phenotypes. A SNP in the olfactory receptor OR51L1 was significantly associated (7.3 × 10−8)
with the DSM-IV criterion of persistent desire to, or inability to, cut down on drinking. LCA
revealed a three-class model: the “low risk” class (50%) rarely endorsed any criteria, and none met
criteria for AD; the “moderate risk” class (33) endorsed primarily 4 DSM-IV criteria, and 48%
met criteria for AD; the “high risk” class (17%) manifested high endorsement probabilities for
most criteria and nearly all (99%) met criteria for AD One single nucleotide polymorphism (SNP)
in a sodium leak channel NALCN demonstrated genome-wide significance with the high risk class
(p=4.1 × 10−8). Analyses in an independent sample did not replicate these associations.
Conclusion—We explored the genetic contribution to several phenotypes derived from the
DSM-IV alcohol dependence criteria. The strongest evidence of association was with SNPs in
NALCN and OR51L1.
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Introduction
Alcohol dependence (AD) is one of the most common and costly public health problems in
the United States and throughout the world, affecting 4-5% of the United States population
in a 12-month period (Kessler, 2005; Li et al., 2007), and 12.5% across the lifetime (Hasin et
al., 2007). Family, twin, and adoption studies have provided convergent evidence for the
role of genetic factors in AD (Goodwin et al., 1974; Heath et al., 1997). Approximately 40%
to 60% of the total variance in risk for AD is due to heritable influences (Prescott et al.,
2006; Schuckit et al., 2001).
To date, a few genes have been shown to be associated with AD, including ADH1B,ALDH2,
ADH4, CHRNA5, CHRM2, GABRA2, and GABRG1 (Agrawal et al., 2012; Covault et al.,
2008; Edenberg et al., 2004; Edenberg and Foroud, 2006; Edenberg et al., 2006; Enoch,
2008; Enoch et al., 2009; Luo et al., 2005; Wang et al., 2009; Wang et al., 2004); however,
the variation in each of these genes accounts for only a small portion of the vulnerability to
AD. This could be due to the study design, the gene coverage, or most likely the complex
etiology and heterogeneity of AD.
The DSM-IV diagnosis of AD requires the manifestation of three or more of the following
criteria at any time during the same 12-month period: tolerance, withdrawal, using alcohol
more than intended, a persistent desire to cut down or inability to do so, spending a great
deal of time obtaining alcohol or recovering from its effects, giving up activities to drink,
and continuing alcohol use despite physical or psychological problems (DSM-IV)
(AmericanPsychiatricAssociation, 1994). The requirement of any three inherently creates a
group of AD individuals that is clinically and likely genetically heterogeneous. Therefore,
approaches that focus on potentially more homogeneous subgroups may increase the power
to identify novel genetic variants by reducing the clinical (and therefore possibly the
genetic) heterogeneity.
We used several complementary approaches to examine the genetic contributions to the risk
of AD. We first analyzed the dichotomous phenotype of AD, because it is the most widely
studied phenotype and most directly reflects the clinically relevant trait. We then examined
each of the DSM-IV criteria for dependence individually, as one approach to reduce
heterogeneity. We also employed latent class analysis to identify subgroups of individuals
defined on the basis of their pattern of endorsement of DSM-IV criteria and used the
probability of class assignment as a quantitative phenotype for analysis. This approach may
also reduce heterogeneity and increase the power to identify genetically similar subgroups.
We utilized a genome-wide approach to detect common genetic variants associated with the
phenotypes. Unlike most studies which employ a case-control design, we performed a
family-based genome-wide association study (GWAS) using extended families densely
affected by AD. The sample was limited to European American (EA) families to reduce one
source of potential heterogeneity.
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Methods
Sample
Alcoholic probands were recruited from inpatient and outpatient treatment facilities through
six sites participating in the Collaborative Study on the Genetics of Alcoholism (COGA)
(Begleiter et al., 1995; Foroud et al., 2000). The probands and their family members were
administered a validated poly-diagnostic interview, the Semi-Structured Assessment for the
Genetics of Alcoholism (SSAGA) (Bucholz et al., 1994; Hesselbrock et al., 1999).
Individuals below the age of 18 were administered an adolescent version of the SSAGA.
Institutional review boards at all sites approved the study.
A sub-sample of COGA families was selected to maximize the contribution of genetic
variants to the risk for AD. All families recruited by COGA were reviewed and prioritized
based on, in preferential order: 1) the largest number of AD family members with DNA; 2)
the largest number of family members with electrophysiology data and DNA; and 3) the
largest number of family members with DNA regardless of other phenotypes. The final
sample consisted of 118 large, multiplex European American families, with DNA available
from 2,322 individuals.
Phenotypes and Statistical Analysis
Phenotypic information for the members of these 118 families was collected using the
SSAGA, with some individuals having multiple assessments across time. If an individual
was interviewed more than once, data from the SSAGA interview with the maximum total
number of endorsed DSM-IV AD criteria was utilized.
Only individuals who reported drinking at least once per month for 6 months or more at any
evaluation (regular drinking) were included in the analysis. Subjects who were 15 years or
older and met DSM-IV criteria at any evaluation were classified as AD (n=687), and
individuals who were 23 years or older and did not meet criteria for DSM-IV AD were
classified as unaffected (n=773). All other individuals were classified as unknown (n=326),
including self-reported AD children at a very early age (< 15 years) and unaffected
individuals who were younger than 23 years old and thus had not fully passed through the
primary age of risk for AD and therefore might still develop it. These 326 individuals were
included in analyses of all other phenotypes.
Latent class analysis (LCA) was conducted to identify subgroups of individuals based on the
pattern of endorsement of the 7 DSM-IV AD criteria (Muthen and Muthen, 1998-2011).
LCA may be viewed as a version of non-parametric cluster analysis, and makes the
assumption of conditional independence (i.e. endorsement of one criterion within a class is
uncorrelated with other criteria). There are two important estimates recovered from LCA: (a)
the prevalence of individual classes of individuals with similar item endorsement profiles
and (b) the likelihood of endorsing an item conditional on class membership. The Bayesian
Information Criteria (BIC) and entropy (reflecting level of misclassification) were utilized to
determine which model (i.e., number of latent classes) provided the best fit to the data.
A critical assumption of LCA is conditional independence and violations can result in
extraction of more classes than are required. To address this concern, we examined a factor
mixture model where a single factor was nested within each latent class, relaxing the
conditional independence assumption. The fit of this model was compared to the LCA. As
the objective of this study was to classify individuals (i.e. person-centered) rather than
symptoms (i.e. item-centered), we did not conduct factor analyses in the absence of LCA.
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Based on the best-fitting model, class membership was utilized in a two-step process. First,
an individual was assigned to the latent class with the highest probability, and discrete class
memberships were compared using post hoc validators such as gender, age at onset of
regular drinking (from the first interview in which the individual began drinking regularly),
and DSM-IV AD. Interpretation of the classes was based on the validators. Gender and
DSM-IV AD differences between classes were assessed with a chi-squared test; number of
DSM-IV criteria, age and age at onset of regular drinking were tested using an analysis of
variance (ANOVA), with gender and birth cohort as covariates. Tukey-adjusted t-tests were
employed to test for pairwise differences when there was a significant (p<0.05) main effect
of latent class assignment.
To optimize the power for genetic analyses, we constructed secondary continuous
phenotypes based on the probability of assignment to each of the three latent classes. As a
result, information describing each latent class provided an interpretation of the three classes
while the probability of being in each class was employed as the phenotype in analysis. This
approach avoids multiple pairwise comparisons of the three classes in analyses, avoids
misclassification inherent in assigning individuals to a particular latent class, maximizes the
number of subjects, and was shown previously to improve power to detect genetic
association (Bureau et al., 2011).
Heritability was estimated using the polygenic option in SOLAR (Almasy and Blangero,
1998) for the following phenotypes: DSM-IV AD, each individual DSM-IV criterion, the
three continuous phenotypes based on the LCA probabilities, and membership in each latent
class. Sex and birth cohort, defined by year of birth (<1930<1930-1949-1950-1969, and
≥1970), were used as covariates for all heritability calculations to account for secular trends
(Grucza et al., 2008) in alcohol use and dependence.
Genotyping and Association Analysis
Genotyping for 2,105 subjects in these 118 families was performed at the Genome
Technology Access Center at Washington University School of Medicine in St. Louis using
the Illumina Human OmniExpress array 12.VI (Illumina, San Diego, CA, USA). In addition,
genotypes previously generated on the Illumina Human 1M-Duo BeadChip (Illumina, San
Diego, CA, USA)by the Center for Inherited Disease Research were also included for 224
subjects from these families (Edenberg et al., 2010). For quality control purposes, 51 of the
2,105 subjects were genotyped on both arrays and available for analysis, prior to sample
exclusions (n=7) due to Mendelian inconsistencies.
Quality control (QC) was first performed on genotype data generated from the
OmniExpress. Genotypes for individuals with a genotype rate <98% were excluded from
analysis, and SNPs with a genotyping rate <98% were excluded from analysis. Further
details can be found in Kang et al (Kang et al., 2012). Genotypes of the 51 overlapping
individuals were then compared. There were 571 of 544,276 SNPs genotyped on both arrays
with two or more non-missing and different genotypes, which were excluded from all
further analyses. There were 442 genotyped founders used to remove SNPs which violated
Hardy-Weinberg equilibrium (HWE; p<10−6). SNPs with minor allele frequency less than
5% were also removed from further analysis. After combining the data generated from the
two arrays in the members of these 118 families, pedigree structure was reviewed and
modified, as described in Kang et al (Kang et al., 2012).
The family-based Generalized Disequilibrium Test (GDT), which employs information from
all discordant relative pairs (Chen et al., 2009), was used to test for association with the
qualitative traits: AD and each DSM-IV criteria. A linear mixed effects model was
employed using the kinship library (lmekin) implemented in R (http://www.inside-r.org/
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packages/cran/kinship/docs/print.lmekin) to test for association with the quantitative traits
reflecting probability of membership in the latent classes. The linear mixed effects model in
the kinship function allows for the covariance matrix to be completely specified for the
random effects. The result is that each family has a different covariance pattern based on the
kinship coefficients, to model the familial genetic random effects. Sex, age at last interview
and birth cohort as well as the first principal component (PC1) from the EIGENSTRAT
analysis were evaluated as potential covariates. Any significantly associated covariate
(p<0.05) was included in all final association models. As described in Wang et al (Wang et
al., 2012) imputed data were generated using BEAGLE 3.3.1(Browning and Browning,
2009) in the chromosomal regions providing the greatest evidence of association with the
genotyped SNPs.
Replication Study
The Study of Addiction: Genetics and Environment (SAGE) was used as an independent
replication sample to evaluate the SNPs showing the greatest evidence of association in the
COGA sample. This is a case-control sample derived from three large, complementary
studies: COGA, the Family Study of Cocaine Dependence and the Collaborative Genetics
Study of Nicotine Dependence (Bierut et al., 2010). The 129 individuals who overlapped
between the 118 pedigrees and SAGE were removed from the replication dataset. The
remaining SAGE samples included 2,647 individuals of European American descent. AD
and individual criteria were obtained from SSAGA data. Imputed dosage data were obtained
using the same method as described above. Plink was used in all analyses, employing age at
interview and gender as covariates.
Results from LCA were derived separately in this sample using Mplus, as described above.
LCA was also conducted in the SAGE+COGA combined sample and in the SAGE sample
including the 129 individuals to examine if latent class assignment was sample-dependent.
This was tested with McNemar's change test.
Results
Sample
Following quality control and the exclusion of some individuals after correction of pedigree
inconsistencies, the final analytic sample included 2,322 genotyped individuals from 118
extended families, of which 1,786 individuals met phenotypic criteria for inclusion (Table
1). The average number of genotyped members per family was 19.6, with an average of 5.9
genotyped individuals per family meeting criteria for DSM-IVAD. A total of 707,557
autosomal SNPs passed quality review. 115,772 SNPs were excluded due to a low minor
allele frequency (<5%). The final dataset consisted of 591,785 SNPs, yielding a genome-
wide threshold of p=8.45 × 10−8. Since the phenotypes examined represent some facet of
AD and additional Bonferroni correction of related phenotypes would be unnecessarily
stringent, this p-value based on the number of SNPs was considered as the significance
threshold.
Latent Class Analysis
The optimum latent class model (by BIC model fitting criteria) was a 3-class model. The
sample-size-adjusted (ssadj) BIC decreased from 13,849 for a 3-class model to 13,827 for a
4-class model, with a corresponding drop in entropy of 0.77 to 0.68. The ssadj BIC from the
factor mixed model was 13,830, with an entropy of 0.768. Due to the similar results between
the two models, a more parsimonious 3-class model which assumed conditional
independence was used in subsequent analyses.
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The criterion endorsement probabilities, conditional on class membership, are shown in
Figure 1 and reveal a range of severity. A low-risk class (50% of individuals) included
individuals with negligible to low endorsement of the dependence criteria. A moderate-risk
class (33% of individuals) was distinguished by individuals with low endorsement
probability of withdrawal, gave up activities to drink and time spent obtaining or recovering
from the effects of alcohol, but higher (>0.51) probabilities of endorsing each of the
remaining criteria. A high-risk class (17% of individuals), included individuals with high
(>0.86) probability of endorsing the 7 dependence criteria.
Table 2a summarizes the characteristics of each of the latent classes and Table 2b provides
summary statistics for the DSM-IV criteria for each latent class. As expected, there were
significantly more DSM-IV AD individuals (X2=1222.3, df=2, p<0.0001) and significantly
more males (X2=66.2, df=2, p<0.0001) in the moderate and high-risk classes. The mean
number of DSM-IV criteria was significantly different among the three classes (overall F(6,
1779)=2043.7, p<0.0001; p<0.0001 for each pairwise comparison), with higher scores in the
high-risk class, indicating that classes reflected a continuum of severity as indexed by
number of DSM-IV criteria. There was a main effect of latent class for age at regular
drinking onset (overall F(6,1779)=83.0, p<0.0001; latent class p<0.0001), and a marginal
effect for age (overall F(6,1779)=2394.0, p<0.0001; latent class p=0.045). The low-risk
class contained no individuals meeting criteria for AD, although some individuals endorsed
tolerance (30%) or drink more than intended (28%). Individuals in this class began drinking
regularly at a significantly older age (19.5 years) than those in the moderate (p<0.0001) or
high-risk (p<0.0001) classes. In the moderate risk class, 66% were AD, with 92% of this
class endorsing drink more than intended, and more than 50% endorsing use despite
physical/psychological problems (56%), persistent desire/inability to cut down (73%), or
tolerance (68%). On average they began regular drinking earlier (17.6 years) than their
counterparts assigned to the low risk class (p<0.0001). The third class was composed
primarily of AD (99%) individuals, with the majority endorsing use despite physical/
psychological problems (98%), drink more than intended (98%), or persistent desire/
inability to cut down (97%). These individuals began drinking at the youngest age (16.8
years) compared to their counterparts in the moderate (p=0.01) and low-risk (p<0.0001)
classes. Individuals in this class were significantly older (55.0 years) than individuals in the
low-risk (46.3 years, p=0.03) but not the moderate-risk (49.3 years, p=0.19) classes. There
were no significant differences in age between the low- and moderate-risk classes (p=0.61)
or between the moderate- and high-risk classes (p=0.19).
Genetic Analysis
Heritability was estimated for DSM-IV AD, each of the DSM-IV criteria, and the three traits
defined by the probability of belonging to each of latent class (Table 3), after covarying for
effects of sex and birth cohort on the phenotype. Heritability for AD was estimated to be
61%. Estimates of heritability for the individual criteria ranged from 59% (drinking more
than intended) to 29% (tolerance). Heritability of membership in the low and high-risk
classes was 0.52 and 0.53. Due to the redundancy of including all three probabilities and the
low heritability of the moderate risk class (0.17), this phenotype was not included in the
GWAS.
Genome-wide results of the association analyses of each phenotype are summarized in
Figure 2, and all associations with p<1.0 × 10−6 are shown in Table 4; Supplemental Table 1
contains results for all SNPs with p<1.0 × 10−5. There was no evidence to suggest inflation
of the association p-values (0.984 < λ < 1.01), validating the choice of the significance
threshold. QQ plots are provided for each phenotype in the Supplemental Material. For
DSM-IV AD the best SNP reached 7.2 × 10−7.
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Two genotyped SNPs reached genome-wide significance (p<8.4 × 10−8). The most
significant result was for a SNP on chromosome 13 in NALCN, (sodium leak channel, non-
selective), rs17484734 (p=4.1 × 10−8, Figure 3A) for the probability of high-risk
membership. This SNP also showed evidence of association with withdrawal (p=1.3 ×
10−7). This SNP is in a recombination hot spot, and thus is not in linkage disequilibrium
(LD) with the surrounding genotyped SNPs. There were no other genotyped SNPs in this
region demonstrating association with these phenotypes. One imputed SNP, rs1151384, in
moderate LD with rs17484734 (r2= 0.80) provided supporting evidence of association with
both phenotypes (p≤1.4 × 10−6 for probability of high risk membership and withdrawal). No
other imputed SNPs were in LD with these two SNPs (r2<0.20).
The DSM-IV criterion persistent desire/inability to cut down on drinking also exceeded
genome-wide significance thresholds for rs11035102, in the olfactory receptor OR51L1
(olfactory receptor, family 51, subfamily L, member 1; p=7.3 × 10−8). Evaluation of
imputed SNPs in this region revealed supporting evidence of genome-wide association for
rs11035097 (p=8.3 × 10−8) in addition to moderate association with six other SNPs all in
high LD with the genotyped SNP (r2≥0.80, all p<9.7 × 10−7). OR51L1 is located in a region
of chromosome 11 with many other olfactory receptors (Figure 3B). The genotyped SNP
also demonstrated suggestive association with drinking despite physical problems (p=2.1 ×
10−6) and with the high-risk latent class probability trait (p=4.9 × 10−5).
Replication of Association Results
LCA was performed in the SAGE sample with comparable results to the COGA sample,
including probabilities of criteria endorsement. When examining class assignments of (a)
SAGE subjects in the SAGE+COGA versus the primary SAGE sample, and (b) the 106
overlapping COGA subjects in SAGE (23 individuals were excluded in the COGA analysis
due to the restriction on regular drinking), a McNemar's change test demonstrated no
significant change in class assignment in the SAGE sample compared to SAGE+COGA nor
in the 106 overlapping individuals (all p>0.72). Nine of the 10 SNPs with top association
results in Table 4 were genotyped in the SAGE data, imputed dosage data was used for
rs12006002, which had not been genotyped in SAGE. The SNPs did not demonstrate
association with any of the phenotypes (all p>0.16).
Discussion
This is the first GWAS to our knowledge that examines each individual criterion of the
DSM-IV AD diagnosis as well as phenotypes defined by the probability of latent class
assignment. As such, it is the first association study demonstrating genome-wide
significance with one of the DSM-IV AD criteria as well as with the phenotype derived from
the probability of membership in the high-risk class. This suggests that characterizing more
homogeneous subgroups of individuals, defined either by a specific AD criterion or by the
probability of belonging to a latent class, increased the power to detect genetic association
relative to the diagnosis of AD, a particularly heterogeneous phenotype. For example,
estimated power was equivalent for the two phenotypes DSM-IV and persistent desire/
inability to cut down, yet one of the strongest association results was with the persistent
desire/inability to cut down, p=7.3 × 10−8, while there was modest evidence of association
with DSM-IV (p=1.5 × 10−5, Supplementaltal Table 1).
We estimated the heritability of AD, the individual DSM-IV criteria, as well as two
continuous phenotypes based on the LCA probabilities. The estimated heritability for AD
(61%) was similar to previous reports (Prescott et al., 2006). However, the heritability
estimates for the individual DSM-IV criteria were slightly larger than previously reported
(Slutske et al., 1999). This may reflect the effects of shared environment, which is known to
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inflate the estimate of the genetic contribution to the trait (Tenesa and Haley, 2013).
Although the phenotypes based on the probabilities of class assignment were less heritable
(≤ 34%), actual membership in each class was more heritable (≥52%). This may be related
to the entropy such that misclassification may have favored the assignment of related
individuals into the same class. The less heritable moderate risk class (17%) could be a
result of environmental influences, and therefore was not examined further.
As seen in Table 4, the individual DSM-IV criteria provided stronger evidence of
association than DSM-IV AD. This suggests that individuals who endorse a specific
criterion may have a more common genetic etiology compared with the heterogeneous
group of AD individuals, who are diagnosed by endorsing different combinations of DSM-
IV criteria. Furthermore, association was observed with a quantitative trait derived from the
probability of belonging to the high-risk latent class, despite its lower heritability estimate
compared to the heritability of AD. This is consistent with Kuo et al. (Kuo et al., 2008), who
found that the first factor derived in a factor analysis was a better fit to a general population
of social drinkers when combined with a latent class framework of three classes of drinkers
(severe, moderate, and non-problem drinkers).
Our goal was to classify individuals, not symptoms and hence, we employed a latent class
approach rather than a factor analysis model defining one continuous latent trait. It is
noteworthy however that the pattern of LCA results obtained here (high, moderate, low,
versus subtypes) are typical of data that are well-suited to factor analysis. The use of latent
class analysis has successfully been employed to examine patterns of alcohol abuse and
dependence symptoms (Beseler et al., 2012; Bucholz et al., 1996; Ko et al., 2010; Moss et
al., 2008) as well as other addictions such as nicotine dependence (Agrawal et al., 2011),
and opioid dependence (Shand et al., 2011). The majority of these studies also found a 3-
class model was the best fit, with the classes representing a severity range from low-risk to
high-risk. There are several advantages to examining individuals according to their risk
profile, including identifying individuals in a trajectory towards future dependence,
distinguishing the best clinical or pharmacological treatment for moderate or at-risk
individuals, and -- importantly for this study – reducing genetic and phenotypic
heterogeneity.
One SNP, rs11035102, which is located in a region of several olfactory genes, showed
genome-wide significant association with having a persistent desire to cut down/inability to
do so criteria for AD, with strong support from several imputed SNPs in high LD (Figure
3B). This SNP was also moderately associated with the criterion of drinking alcohol despite
physical/psychological consequences in the present study and with the total number of
DSM-IV criteria (symptom count) in the same COGA family sample (p=3.8 × 10−5, Wang
et al., 2012; Supplemental Table 2). This gene is near two olfactory receptors (OR52E2,
OR52J3, seen in Figure 3B) shown previously to be significantly associated with number of
cigarettes smoked per day in a pathway analysis across three independent cohorts
ascertained on nicotine or AD, one of which was the COGA sample (Harari et al., 2012). In
a study of opioid-dependent individuals, the desire/inability to cut down was found to be one
of the most prevalent substance use disorder criteria across five substances of abuse,
including alcohol (Wu et al., 2012). Although this was not the most prevalent criterion in
our sample, it was the criterion with the most diverse group of people, with 7% of the
individuals endorsing this criterion being in the low-risk class, 53% from the moderate-risk
class and 40% from the high-risk class. There is strong evidence supporting a relationship
between learned olfactory sensory cues and alcohol consumption and dependence. It was
shown that after alcohol odor stimuli, alcoholics found it more difficult to resist a drink than
before the stimuli (Stormark et al., 1995). Priming subjects with an alcohol odor also
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increased activation of the limbic system (Bragulat et al., 2008) and led to enhanced craving
for alcohol (Kareken et al., 2010; Kareken et al., 2004).
The strongest association was between a SNP in a nonselective sodium leak channel NALCN
and the probability of high-risk membership. This SNP, rs17484734, is in a recombination
hotspot (Figure 3A). As a result, only one imputed SNP provided supporting evidence for
association. This channel can be activated by several peptides including acetylcholine and
substance P, both of which have been shown to interact with alcohol. Acetylcholine is
released when alcohol binds to the nicotinic acetylcholine receptors as an agonist (Bito-
Onon et al., 2011; Feduccia et al., 2012). Substance P, through interaction with the
neurokinin 1 receptor, has been implicated in alcohol consumption, preference, and
reinstatement, and is a potential therapeutic target for AD (Schank et al., 2012). One of the
components of the NALCN complex is UNC79, the homolog of which was shown to
increase alcohol consumption in mice and led to increased sensitivity to alcohol in C.
elegans (Speca et al., 2010).
Six of the SNPs presented in Table 4 also demonstrated moderate association with symptom
count (rs17484734, rs12006002, rs2029519, rs4479194, rs7172677, rs11035102; all p<7.9 ×
10−5) (Wang et al., 2012). The most significant association reported with the symptom count
phenotype was with rs12903120 in C15orf53. This SNP was not associated with any of the
phenotypes examined in this study (0.36≤p≤2.7 × 10−5). Since the symptom count
phenotype is the total number of endorsed DSM-IV criteria, we might have expected more
overlap between results with the individual criterion. However, there are several possible
explanations for the observed differences. First, if our hypothesis is correct that different
genetic factors may contribute to each criterion, then analyzing them separately would be a
more powerful approach to identify the individual genetic effects. Second, there are some
differences in the sample used in these two analyses as well as the analytic methods. For
example, in the analyses reported herein, we employed a stricter inclusion criterion that only
allowed regular drinkers. Previous analyses of alcohol symptom count utilized a more
inclusive criterion that included all individuals reporting to have ever consumed alcohol.
We did not find additional support in the SAGE sample. This may be due to several factors.
First, the power to replicate findings of relatively small effect, such as those identified in this
sample, is modest in replication samples of the size of SAGE. Second, the COGA family
GWAS sample is quite unique in that the families were selected because of their large size
and density of AD. Much of the SAGE sample consists of individuals recruited for nicotine
and cocaine, then selected for comorbid AD. The risk factors contributing to AD and our
AD-related phenotypes may be different from those more commonly found in sporadic AD
or AD associated with other substance dependence. Finally, the lack of replication may be
that our initial COGA findings are false positive associations. Clearly, further studies,
ideally in family samples ascertained for a high level of AD, are necessary.
The design of this study has several strengths. First, because most families have a strong
history of AD, the sample is likely enriched for a greater genetic contribution to risk.
Second, family-based analysis is robust to population substructures such as slight
differences in ethnicity. This family-based design has been previously used to test for
association with event-related brain oscillations correlated with deficits in alcoholics and
offspring who are at risk for AD, with genome-wide significant association (p = 4.7 × 10−10)
of SNPs in KCNJ6 (Kang et al., 2012). We did not correct the significance threshold for the
number of phenotypes analyzed; however, there was no indication of inflated association
results, and the correlated phenotypes are all related to AD. A weakness of the study is the
cross-sectional nature of the phenotypes employed. Thus a longitudinal investigation to
follow-up on individuals in the low-risk and especially those in the moderate-risk classes
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who are not yet AD could provide insight as to clusters of individuals who change latent
classes over time, and further evidence of the validity of employing homogenous phenotypes
and suggest a genetic mechanism of liability.
In summary, this family-based GWAS demonstrated two genome-wide significant
associations, one of a polymorphism in an olfactory receptor with the persistent desire or
inability to cut down on alcohol consumption, and the other with a sodium leak channel and
the high-risk latent class trait. These results validate the advantage of defining a more
homogenous sample in which to analyze genetic associations. These results combined with
those of other recent studies (Kang et al., 2012; Wang et al., 2012) also demonstrate the
valuable resource of the densely affected European American families of COGA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Average probability of DSM-IV criterion endorsement within each latent class
The X-axis indicates the DSM-IV criteria. The Y-axis denotes the probability of endorsing
each criterion within each latent class. The low-risk class is depicted with a dotted line. The
moderate-risk class is depicted with a dashed line. The high-risk class is depicted with a
solid line.
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Figure 2. Genome-wide association study results for the phenotypes
(A) alcohol dependence, (B) withdrawal, (C) gave up activities to drink, (D) time spent
obtaining/using/recovering from alcohol, (E) drink despite physical/psychological problems,
(F) persistent desire/inability to cut down, (G) tolerance, (H) drink more than intend to, (I)
low-risk latent class probability, (J) moderate-risk latent class probability, (K) high-risk
latent class probability.
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Figure 3. Association results with key phenotypes
(A) High-risk latent class probability with SNPs in the region around rs17484734 in
NALCN. (B) Persistent desire/inability to cut down with SNPs in the region around
rs11035201 in OR51L1. Y-axis denotes the –log10(p-value) for association. X-axis is the
physical position on the chromosome (Mb). The most significantly associated SNP is shown
in purple. The extent of linkage disequilibrium (as measured by r2) between each SNP and
the most significantly associated SNP is indicated by the color scale at top right. Larger
values of r2 indicate greater linkage disequilibrium. Genotyped SNPs are indicated as
circles, and imputed SNPs by squares.
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